Showing results (521-530 of 635) with videos related to
Sort By:
Pageof 64
Journal of Experimental & Clinical Cancer Research : CR|May 25, 2019
Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitorsM Mancini, S De Santis, C Monaldi, et al.Scientific Reports|April 8, 2021
New cladotherian mammal from southern Chile and the evolution of mesungulatid meridiolestidans at the dusk of the Mesozoic eraAgustín G Martinelli, Sergio Soto-Acuña, Francisco J Goin, et al.Blood|March 25, 2000
Engraftment, clinical, and molecular follow-up of patients with multiple myeloma who were reinfused with highly purified CD34+ cells to support single or tandem high-dose chemotherapyR M Lemoli, G Martinelli, E Zamagni, et al.Transplantation Proceedings|September 27, 2005
Portal vein arterialization: a new surgical option against acute liver failure?B Nardo, P Caraceni, R Montalti, et al.Bone Marrow Transplantation|October 9, 2007
Current status and future perspectives for yttrium-90 ((90)Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphomaC Gisselbrecht, W Bethge, R F Duarte, et al.Leukemia|August 30, 2002
Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot studyP P Piccaluga, G Visani, S A Pileri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 3, 2001
High incidence of central nervous system involvement in patients with metastatic or locally advanced breast cancer treated with epirubicin and docetaxelD Crivellari, O Pagani, A Veronesi, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Hematopoietic progenitor cell collection and neoplastic cell contamination in breast cancer patients receiving chemotherapy plus granulocyte-colony stimulating factor (G-CSF) or G-CSF alone for mobilizationF Bertolini, A Lanza, F Peccatori, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 15, 2000
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapyF Ferrara, F Morabito, B Martino, et al.European Journal of Cancer (Oxford, England : 1990)|April 26, 2020
2-deoxy-2[F-18] fluoro-D-glucose positron emission tomography Deauville scale and core-needle biopsy to determine successful management after six doxorubicin, bleomycin, vinblastine and dacarbazine cycles in advanced-stage Hodgkin lymphomaM Picardi, R Fonti, R Della Pepa, et al.Pageof 64